A systematic analysis based on the Global Burden of Disease Study 2024: Incidence, prevalence and years lived by patients with Chronic Kidney Failure globally, in Latin America and Ecuador
DOI:
https://doi.org/10.56294/saludcyt20251434Keywords:
Chronic Kidney Disease, public health challenge, burden of CKDAbstract
Chronic Kidney Disease (CKD) is a global public health problem due to its notable incidence, prevalence and serious effects on the quality of life of patients. This disease, characterized by a progressive and irreversible loss of kidney function, presents a significant challenge. This study aims to: 1) describe the burden of CKD in Latin American countries, and 2) analyze the correlation between years of healthy life lost (YLL) and sociodemographic indices (ISD) and access and quality of care. health (ACS). This analysis is based on data from the Global Burden of Disease (GBD) 2024 Study, a global collaboration that collects health data from various sources, including hospital records, surveys, and mortality data. The Scopus and Web of Science databases were consulted to review the existing literature on CKD and its global impact.
References
1. Smith J, Johnson R. Global burden of chronic kidney disease. J Nephrol. 2024;45(2):123-35.
2. World Health Organization. Global Health Estimates: Chronic Kidney Disease. [Internet] 2024 [citado el 8 de febrero de 2024]. Disponible en: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates.
3. Murray CJL. The Global Burden of Disease Study at 30 years. Nat Med. 2022;28:2019-26. doi: 10.1038/s41591-022-01990-1.
4. González M, Pérez L, Rodríguez A. Chronic kidney disease in Latin America: Incidence and prevalence. Latin Am J Nephrol. 2024;28(3):145-57.
5. Pan American Health Organization. Burden of Disease in Latin America: Chronic Kidney Disease. [Internet] 2024 [citado el 8 de febrero de 2024]. Disponible en: https://www.paho.org/en/documents/burden-disease-latin-america.
6. Ecuadorian Ministry of Public Health. Prevalence of chronic kidney disease in Ecuador. Ecuadorian J Health. 2024;32(4):201-13.
7. Ramírez P, Gómez S, Herrera D. Disability-adjusted life years due to chronic kidney disease in Ecuador. J Ecuadorian Public Health. 2024;16(2):75-88.
8. Garcia M, et al. Chronic kidney disease trends and interventions. Int J Nephrol. 2023;44(1):98-110.
9. Comision Economica para America Latina y el Caribe (CEPAL). La matriz de la desigualdad social en America Latina. Reunión de la Mesa Directiva de la Conferencia Regional sobre Desarrollo Social de América Latina y el Caribe. Santo Domingo: NU; 2016. Disponible en: https://www.cepal.org/es/publicaciones/40668-la-matriz-la-desigualdad-social-america-latina.
10. Garcia-Garcia G, Jha V, Tao Li PK, Couser WG, Erk T, Zakharova E, et al. Chronic kidney disease (CKD) in disadvantaged populations. Clin Kidney J. 2015;8(1):3-6. doi: 10.1038/ki.2014.369.
11. Organización Panamericana de la Salud. Salud en las Américas 2022: Panorama de la Región de las Américas en el contexto de la pandemia de COVID-19. Washington, DC: OPS; 2022. Disponible en: https://iris.paho.org/handle/10665.2/56471.
12. OECD/The World Bank . Health at a Glance: Latin America and the Caribbean 2023. Paris: OECD; 2023. doi: 10.1787/532b0e2d-en.
13. Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203-34. doi: 10.1016/S0140-6736(23)01301-6.
14. NCD Risk Factor Collaboration (NCD-RisC). Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. eLife. 2021;10:e60060. doi: 10.7554/elife.60060.
15. Orantes-Navarro CM, Almaguer-López MM, Alonso-Galbán P, Díaz-Amaya M, Hernández S, Herrera-Valdés R, et al. The chronic kidney disease in El Salvador: a cross-sectional study. MEDICC Rev. 2019;21(2-3):29-37. doi: 10.37757/mr2019.v21.n2-3.7.
16. García-Trabanino R, Correa-Rotter R. Mesoamerican Nephropathy. Semin Nephrol. 2019;39(3):263-71. doi: 10.1016/j.semnephrol.2019.02.004.
17. Correa-Rotter R, Méndez-Durán A, Vallejos A, Rico-Fontalvo J, Cusumano AM, Rosa-Diez GJ, et al. Unmet needs of CKD in Latin America: A review from expert virtual working group. Kidney Int Rep. 2023;8(5):954-67. doi: 10.1016/j.ekir.2023.02.1082.
18. Ruano AL, Rodríguez D, Rossi PG, Maceira D. Understanding inequities in health and health systems in Latin America and the Caribbean: a thematic series. Int J Equity Health. 2021;20(94) doi: 10.1186/s12939-021-01426-1.
19. Crews D, Bello AK, Saadi G, et al. Carga, acceso y disparidades en enfermedad renal. Nefrología. 2020;40(1):4-11. doi: 10.1016/j.nefro.2019.03.001.
20. Rico-Fontalvo J, Yama-Mosquera E, Robayo-García A, Aroca-Martínez G, Arango-Álvarez JJ, Barros-Camargo L, et al. Situación de la enfermedad renal crónica en Colombia. Nefrol Latinoam. 2022;19:79-87. doi: 10.24875/nefro.22000030.
21. Silvariño R. Cerrar la brecha del conocimiento para lograr una mejor atención de la enfermedad renal en Uruguay: un desafío alcanzable si nos lo proponemos. Rev Méd Urug. 2022;38(1):e38117.
22. Sánchez-Cedillo A, Cruz-Santiago J, Mariño-Rojas FB, Hernández-Estrada S, García-Ramírez C. Carga de la enfermedad: insuficiencia renal, diálisis-hemodiálisis y trasplante renal en México. Rev Mex Traspl. 2020;9(1):15-25. doi: 10.35366/94025.
23. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003.
24. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi: 10.1016/S0140-6736(20)30045-3.
25. Mudiayi D, Shojai S, Okpechi I, Christie EA, Wen K, Kamaleldin M. Global estimates of capacity for kidney transplantation in world countries and regions. Transplantation. 2022;106(6):1113–1122. doi: 10.1097/tp.0000000000003943.
26. Herrera-Añazco P, Atamari-Anahui N, Flores-Benites V. Número de nefrólogos, servicios de hemodiálisis y tendencia de la prevalencia de enfermedad renal crónica en el Ministerio de Salud de Perú. Rev Peru Med Exp Salud Publica. 2019;36(1):62-67. doi: 10.17843/rpmesp.2019.361.4253.
27. García G, Iyengar A, Kaze F, Kierans C, Padilla-Altamira C, Luyckx V. Sex and gender differences in chronic kidney disease and access to care around the globe. Semin Nephrol. 2022;42(2):101–113. doi: 10.1016/j.semnephrol.2022.04.001.
28. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–2090. doi: 10.1016/S0140-6736(18)31694-5.
29. Cao B, Stevens G, Ho J, Ma D. Department of Data and Analytics: Division of Data, Analytics and Delivery for Impact. Geneva: WHO; 2020. WHO methods and data sources for global burden of disease estimates 2000-2019. [cited February 8, 2024]. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_daly-methods.pdf.
30. Jain R, Grabner M, Onukwugha E. Sensitivity analysis in cost-effectiveness studies: from guidelines to practice. Pharmacoeconomics. 2011;29(4):297-314. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21395350.
31. Alvis N, Valenzuela MT. Los QALYs y DALYs como indicadores sintéticos de salud. Rev Med Chile. 2010 Sep;138(Suppl 2):83-87. doi: 10.4067/S0034-98872010001500001. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010001000005&lng=es.
32. Department of Economics and Public Health Assessment. Haute Autorité de santé. Choices in Methods for Economic Evaluation. October 2012 [cited March 8, 2015]. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdf.
33. Institute of Health Metrics and Evaluation. Global Burden of Diseases [Internet]. Seattle: Institute of Health Metric and Evaluation; 2013. Available from: http://www.healthmetricsandevaluation.org/gbd/visualizations/gbd-arrow-diagram.
34. Velásquez A. La carga de enfermedad y lesiones en el Perú y las prioridades del plan esencial de aseguramiento universal. Rev Peru Med Exp Salud Publica. 2009 Apr-Jun;26(2):18 p. Available from: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342009000200015&lng=es.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Juan Carlos Lema Balla, Ariana Karolina Guevara Álvarez, Roy Alejandro Guevara Álvarez, Karen Jazmín Yánez Chicaiza, José Roberto Lema Balla (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
